Clinical Trials Logo

Insulin clinical trials

View clinical trials related to Insulin.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05464966 Completed - Insulin Clinical Trials

The Primary Objective of This Study Was to Investigate the Effect of Insulin on Myocardial Perfusion and Cardiac Function in Patients Undergoing Cardiac Surgery for CPB Using Transesophageal Echocardiography (TEE) to Detect CSBF

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The primary objective of this clinical trial was to investigate the effects of insulin on myocardial blood flow reflected by CSBF which was evaluated by TEE. The second aim was to observe the effect of insulin on cardiac function and markers of myocardial damage.

NCT ID: NCT05448378 Completed - Insulin Clinical Trials

Evaluation of D-chiro-inositol Treatments

Start date: June 4, 2022
Phase: N/A
Study type: Interventional

Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month. We will evaluate metabolic and hormonal.parameters, as insulienmia, glycemia, estradiol, testosterone.

NCT ID: NCT04739371 Completed - Insulin Clinical Trials

Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)

FIINAAL
Start date: June 17, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to investigate brain insulin's relationship with food intake in African Americans. Facilitating insulin's entrance into the brain through a nasal spray is currently being studied as a way to prevent or treat Alzheimer's disease. However, brain insulin may also have an impact on food intake. This study is designed to help researchers understand how different factors related to Alzheimer's disease (i.e. APOE genotype and cognitive functioning) influence brain insulin's relationship with food intake.

NCT ID: NCT04711382 Completed - Type 1 Diabetes Clinical Trials

The Use of Faster Acting Aspart in Type 1 Diabetes Patients

Start date: January 29, 2018
Phase:
Study type: Observational

Data on switching from traditional mealtime insulins to fast-acting insulin aspart (Fiasp) in routine clinical practice are sparse. The aim was to evaluate the efficacy and safety of switching from traditional mealtime insulin to Fiasp in a "real-world" clinical practice setting in people with type 1 diabetes in Belgium.

NCT ID: NCT04383990 Completed - Type1diabetes Clinical Trials

Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan

Start date: February 28, 2020
Phase: N/A
Study type: Interventional

To compare different timing of insulin Glargine administration (early-6 pm versus standard bedtime-10 pm) as part of standard of care in patients with type1 diabetes who wish to fast the month of Ramadan.

NCT ID: NCT04310280 Completed - Wound Healing Clinical Trials

Effects of Local Insulin on Varicose Ulcers for Wound Healing

Start date: June 1, 2019
Phase: Phase 3
Study type: Interventional

A randomized, split-plot, double-blind, placebo-controlled trial. The varicose ulcer is divided into two (side A and B). Half of the wound's surface is treated locally with insulin (Glargine) applied at an approx depth of 3-4 mm. Treatment with insulin is administered for 7 days. Biopsy specimens of the two sides are obtained on days 0 and 7. A thermographic photograph of the wound is taken at days 0 and 7. The number of blood vessels and fibroplasia is evaluated as the main outcome.

NCT ID: NCT04292535 Completed - Exercise Clinical Trials

Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

Start date: June 15, 2018
Phase: Phase 2
Study type: Interventional

To determine if physical activity engagement alters the dose-response profile and safety of administration of insulin into the intranasal mucosa.

NCT ID: NCT03728647 Completed - Clinical trials for Type 2 Diabetes Mellitus

The Effectiveness of Multimedia Education for Patients With Type 2 Diabe Mellitus

Start date: August 16, 2013
Phase: N/A
Study type: Interventional

A total of 72 type 2 diabetes who began insulin therapy using a pen injector participated in this study. The experimental (n = 36) and control (n = 36) groups received multimedia and regular health education program. Four structured questionnaires were used, and videotapes were applied to demonstrate injection skills.

NCT ID: NCT02914730 Completed - Diabetes Clinical Trials

Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections

Start date: September 2016
Phase:
Study type: Observational

In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on > 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone app.

NCT ID: NCT02666586 Completed - Appetite Clinical Trials

Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control

Start date: January 2016
Phase: N/A
Study type: Interventional

To describe the effect and mechanisms of action faba bean powder and fractions (protein, starch and fiber) on glucose and insulin homeostasis, food intake, satiety and metabolic regulation in young adults (18 to 30 years).